The headquarters is Yunnan Yunlong Pharmaceutical Co., Ltd., which was established in February 2004 and was officially approved by the Yunnan Provincial Administration for Industry and Commerce in August 2011 to change its name to Yunnan Yunlong Pharmaceutical Joint-stock Co., Ltd. The company takes revitalizing China's traditional Chinese medicine industry as its mission and aims to become one of China's * excellent pharmaceutical enterprises. The company is located at Jinghong Road, Kunming National Economic and Technological Development Zone, with registered capital of RMB one hundred million yuan. The plant and office buildings occupy a total area of 58 mu (10 mu in the Economic and Technological Development Zone and 48 mu in Chenggong Industrial Park). The company has established a national marketing center in Huide Building, Haoxian Road, Yuexiu District, Guangzhou, an economically developed and transportation-convenient area. The marketing center has an office area of 498 square meters, which is self-owned property. The company was recognized as a "High-tech Enterprise" in November 2011 and passed re-examination in September 2014. The company owns three independent invention patents and 11 registered trademarks, among which the "Yunlong" trademark was rated as a "Yunnan Famous Trademark" in February 2012. The company has strong production and management technical strength, and all production lines passed the new GMP certification on September 26, 2014. In addition to the invention patents it already owns, the company has three patents that have been applied for and accepted, forming its own proprietary patent technology, and applying its proprietary patent technology to technical services and products, making it an important technical support for the company's products. All products formed by the company belong to the "High-tech Fields Supported by the State", specifically: biomedical technology and traditional Chinese medicine, natural drugs - innovative drugs. In particular, the soft capsule series products are currently the largest producer of soft capsule series products in Yunnan Province, with multiple nationally exclusive varieties and national patented varieties. Among them, the exclusive product Manlong Liquid is exported to Southeast Asia and sells well at home and abroad. The exclusive dosage form and patented variety Biyuan Soft Capsules have been selling well in the market for more than 10 years. The exclusive dosage form product Xingxiang Tu'erfeng Soft Capsules is a * gynecological drug variety. The traditional Chinese medicine antibiotic Huangtengsu Soft Capsules have the largest market share in the country. Since its founding, Yunnan Yunlong Pharmaceutical Joint-stock Co., Ltd. has always shouldered the era's responsibility and sacred mission of carrying forward traditional Chinese medicine and pioneering the cause of human life and health. It upholds the corporate philosophy of "only discovery and invention can lead to development; only innovation and creation can lead to entrepreneurship", is committed to innovation and exploration in the integrated development of biotechnology and modern traditional Chinese medicine, and pursues the principle of integrity-based operation, making unremitting efforts to achieve the health cause and social harmony!
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows